What intramuscular dose of ketorolac (Toradol) should be given to an adult with a headache?

Intramuscular Ketorolac Dosing for Headache

For adults with headache, administer 30 mg of ketorolac intramuscularly, though 60 mg IM has been studied and may be used for severe migraine, recognizing that doses above 30 mg may not provide additional analgesic benefit due to a ceiling effect.

Dosing Recommendations

Standard Adult Dose

• 30 mg IM is the most commonly studied and effective dose for acute headache treatment 1, 2, 3
• This dose provides significant pain reduction within 30-60 minutes of administration

Higher Dose Considerations

• 60 mg IM has been studied specifically for migraine headache 1, 4, 2
• However, evidence suggests an analgesic ceiling effect exists above 10-15 mg for parenteral ketorolac, meaning higher doses may not provide proportionally greater pain relief 5, 6
• A study comparing 60 mg to lower doses found no significant difference in pain reduction or need for rescue analgesia 6

Clinical Context and Evidence

Efficacy Profile

Ketorolac demonstrates robust efficacy for acute headache:

• In migraine headache, 60 mg IM ketorolac reduced mean pain scores from 4.07 to 0.73 over 2 hours 1
• For tension-type headache, 60 mg IM was significantly better than placebo at 30 minutes and 1 hour 3
• Ketorolac shows comparable efficacy to phenothiazines and metoclopramide for migraine treatment 7

Important Caveats

Guideline-Based Treatment Hierarchy: The most recent ACP guidelines (2025) do not specifically recommend ketorolac as first-line therapy. Instead, they recommend:

• NSAIDs combined with triptans for moderate-to-severe migraine 8
• The VA/DoD guidelines (2024) recommend triptans, aspirin-acetaminophen-caffeine combinations, or standard NSAIDs (ibuprofen, naproxen) as preferred agents 9

Ketorolac's Role:

• Ketorolac is not mentioned in the latest migraine treatment guidelines, suggesting it should be considered a second-line or alternative option when preferred agents are contraindicated or unavailable
• It may be particularly useful when oral administration is not feasible due to nausea/vomiting

Safety Considerations

• Adverse effects were infrequent (0.9%) in studies using 30 mg doses 5
• No significant difference in adverse events between 15-30 mg and 30-60 mg dosing 6
• Standard NSAID precautions apply: avoid in renal impairment, active GI bleeding, or cardiovascular disease

Practical Algorithm

1. First-line: Consider oral NSAIDs + triptans per current guidelines 8, 9
2. If parenteral therapy needed: Use ketorolac 30 mg IM
3. Avoid doses >30 mg given ceiling effect and lack of additional benefit
4. Reassess at 30-60 minutes for response
5. Consider rescue medication if inadequate response (occurs in approximately 5-7% of patients) 5

The 30 mg IM dose represents the optimal balance between efficacy and safety, with higher doses offering no meaningful clinical advantage 6.